DNA X Inc.
Organization details
- Legal name
- DNA X Inc.
- Former names
- Sonim Technologies Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3661 — Telephone & Telegraph Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SONM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001178697
- EIN
- 94-3336783
- Wikidata ID
- Q1225892
Board of directors
-
Alan B. Howe · DirectorSince 2023
-
George Thangadurai · DirectorSince 2025
-
Hao Peter Liu · Director · Chief Executive OfficerSince 2023
-
Jack Steenstra · DirectorSince 2023
-
James S. Cassano · DirectorSince 2023
-
Jeffrey Wang · DirectorSince 2023
-
Michael C. Mulica · Director · Acting CEOSince 2023
Chief executives
Director election results
Annual meeting of July 17, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
56.4%
-
85.9%
-
85.9%
-
90.0%
Board connections
2 of this board's directors also sit on 4 other boards. 1 is in the same sector.
- via Alan B. Howe
- via Alan B. Howe
-
QumulusAI Inc. Same sectorvia Michael C. Mulica
- via Alan B. Howe
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 9, 2026 | Crolius Clayton Officer (Chief Financial Officer) | Grant or award | +35,000 | — | — |
| Feb 9, 2026 | Michael C. Mulica Director, Officer (Acting CEO) | Grant or award | +50,000 | — | — |
| Jun 30, 2025 | LYTTON LAURENCE W 10% owner | Open-market sale | −400,514 | $1.39 | $556,714 |
| Jun 26, 2025 | LYTTON LAURENCE W 10% owner | Open-market sale | −466,402 | $1.50 | $699,603 |
| Apr 23, 2025 | James S. Cassano Director | Open-market sale | −23,381 | $1.45 | $33,902 |
| Apr 23, 2025 | Michael C. Mulica Director | Open-market sale | −27,818 | $1.45 | $40,336 |
| Apr 23, 2025 | Jack Steenstra Director | Open-market sale | −23,381 | $1.45 | $33,902 |
| Apr 23, 2025 | Becher Charles Officer (See Remarks) | Open-market sale | −31,326 | $1.45 | $45,423 |
| Apr 23, 2025 | Jeffrey Wang Director | Open-market sale | −4,478 | $1.45 | $6,493 |
| Apr 23, 2025 | Crolius Clayton Officer (Chief Financial Officer) | Open-market sale | −11,634 | $1.45 | $16,869 |
| Mar 31, 2025 | Michael C. Mulica Director | Grant or award | +46,728 | — | — |
| Mar 31, 2025 | Jack Steenstra Director | Grant or award | +46,728 | — | — |
| Mar 31, 2025 | James S. Cassano Director | Grant or award | +46,728 | — | — |
| Feb 6, 2025 | Hao Peter Liu Director, Officer (Chief Executive Officer) | Grant or award | +63,604 | — | — |
| Feb 6, 2025 | Becher Charles Officer (See Remarks) | Grant or award | +70,671 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about DNA X Inc.
Who is the CEO of DNA X Inc.?
Hao Peter Liu is DNA X Inc.'s Chief Executive Officer.
How many directors are on DNA X Inc.'s board?
DNA X Inc.'s board has 7 directors: Alan B. Howe, George Thangadurai, Hao Peter Liu, Jack Steenstra, James S. Cassano, Jeffrey Wang and Michael C. Mulica.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="dna-x-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.